Zoetis Honored with Animal Pharm Award
January 31, 2020
This week, Zoetis was named Best Company, North America in the 2019 Animal Pharm Awards competition. Animal Pharm, the most widely read newsletter reporting on the animal health industry, announced the award winners on January 30, 2020.
This week, Zoetis was named Best Company, North America in the 2019 Animal Pharm Awards competition. Animal Pharm, the most widely read newsletter reporting on the animal health industry, announced the award winners on January 30, 2020.
In announcing the honor, Animal Pharm stated, “Zoetis matched financial vitality with ongoing innovation and several forward-thinking deals, as it continues to lead the way in the animal health sector." Animal Pharm also cited Zoetis’ financial performance, innovation-driven growth, acquisitions and the appointment of Kristin Peck as CEO as reasons for selecting Zoetis this year.
Animal Pharm's annual industry awards honor achievements within the animal health sector over the calendar year. Subscribers can nominate companies, products and employees in 12 award categories. A panel of judges comprised of industry experts evaluate the nominations and select the winners.
In past years, Animal Pharm has recognized Zoetis with Best New Product – Companion Animal for Core EQ InnovatorTM (2018) and Cytopoint® (2016) as well as Best New Product Portfolio – Companion Animal for new canine products launched in 2016, including Cytopoint®, Simparica® (sarolaner) and Vanguard® vaccines. Additionally, Pharmaq was named Best Company in Europe in 2015, the year it was acquired by Zoetis.